Valerie McGuire1, Christine A Jesser, Alice S Whittemore. 1. Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California 94305-5405, USA. vmcguire@leland.stanford.edu
Abstract
OBJECTIVE: Invasive epithelial ovarian cancer is a highly fatal disease, diagnosed at advanced stages when survival is poor. Relatively little is known about the variation in survival across U.S. women of different race/ethnicities. To investigate this issue, we evaluated pathological characteristics and death rates due to invasive epithelial ovarian cancer in a population-based sample of patients from six racial/ethnic groups. METHODS: The analysis included 38,012 women diagnosed with primary invasive epithelial ovarian cancer between 1973 and 1997 in the Surveillance, Epidemiology and End Results Program of the National Cancer Institute. RESULTS: Filipina patients were younger at diagnosis, more likely to have localized disease, and had more mucinous cancers than whites. African-Americans were more likely than whites to be diagnosed at older ages, with distant disease and with undifferentiated/unclassified cancers. After adjusting for age at diagnosis, stage of disease at diagnosis, and cancer histology, we found that, compared to whites, death rates were significantly elevated among African-Americans and significantly reduced among Hispanics and Filipina. We also found that death rates declined significantly with time since diagnosis among women with advanced disease. CONCLUSION: The declining death rates in women with advanced disease suggest the presence of considerable prognostic heterogeneity among these women, which could reflect differences in quality of care. This issue, as well as the survival disadvantage for African-American women and survival advantages for Hispanic and Filipina women, needs investigation.
OBJECTIVE:Invasive epithelial ovarian cancer is a highly fatal disease, diagnosed at advanced stages when survival is poor. Relatively little is known about the variation in survival across U.S. women of different race/ethnicities. To investigate this issue, we evaluated pathological characteristics and death rates due to invasive epithelial ovarian cancer in a population-based sample of patients from six racial/ethnic groups. METHODS: The analysis included 38,012 women diagnosed with primary invasive epithelial ovarian cancer between 1973 and 1997 in the Surveillance, Epidemiology and End Results Program of the National Cancer Institute. RESULTS: Filipina patients were younger at diagnosis, more likely to have localized disease, and had more mucinous cancers than whites. African-Americans were more likely than whites to be diagnosed at older ages, with distant disease and with undifferentiated/unclassified cancers. After adjusting for age at diagnosis, stage of disease at diagnosis, and cancer histology, we found that, compared to whites, death rates were significantly elevated among African-Americans and significantly reduced among Hispanics and Filipina. We also found that death rates declined significantly with time since diagnosis among women with advanced disease. CONCLUSION: The declining death rates in women with advanced disease suggest the presence of considerable prognostic heterogeneity among these women, which could reflect differences in quality of care. This issue, as well as the survival disadvantage for African-American women and survival advantages for Hispanic and Filipina women, needs investigation.
Authors: Stacey J Winham; Nicholas B Larson; Sebastian M Armasu; Zachary C Fogarty; Melissa C Larson; Brian M McCauley; Chen Wang; Kate Lawrenson; Simon Gayther; Julie M Cunningham; Brooke L Fridley; Ellen L Goode Journal: Hum Mol Genet Date: 2019-04-15 Impact factor: 6.150
Authors: Jennifer M Rubatt; Kathleen M Darcy; Chunqiao Tian; Franco Muggia; Rajiv Dhir; Deborah K Armstrong; Michael A Bookman; Laura J Niedernhofer; Julie Deloia; Michael Birrer; Thomas Carl Krivak Journal: Gynecol Oncol Date: 2012-01-16 Impact factor: 5.482
Authors: Robert E Bristow; Matthew A Powell; Noor Al-Hammadi; Ling Chen; J Philip Miller; Phillip Y Roland; David G Mutch; William A Cliby Journal: J Natl Cancer Inst Date: 2013-03-28 Impact factor: 13.506
Authors: Stacey J Winham; Ailith Pirie; Yian Ann Chen; Melissa C Larson; Zachary C Fogarty; Madalene A Earp; Hoda Anton-Culver; Elisa V Bandera; Daniel Cramer; Jennifer A Doherty; Marc T Goodman; Jacek Gronwald; Beth Y Karlan; Susanne K Kjaer; Douglas A Levine; Usha Menon; Roberta B Ness; Celeste L Pearce; Tanja Pejovic; Mary Anne Rossing; Nicolas Wentzensen; Yukie T Bean; Maria Bisogna; Louise A Brinton; Michael E Carney; Julie M Cunningham; Cezary Cybulski; Anna deFazio; Ed M Dicks; Robert P Edwards; Simon A Gayther; Aleksandra Gentry-Maharaj; Martin Gore; Edwin S Iversen; Allan Jensen; Sharon E Johnatty; Jenny Lester; Hui-Yi Lin; Jolanta Lissowska; Jan Lubinski; Janusz Menkiszak; Francesmary Modugno; Kirsten B Moysich; Irene Orlow; Malcolm C Pike; Susan J Ramus; Honglin Song; Kathryn L Terry; Pamela J Thompson; Jonathan P Tyrer; David J van den Berg; Robert A Vierkant; Allison F Vitonis; Christine Walsh; Lynne R Wilkens; Anna H Wu; Hannah Yang; Argyrios Ziogas; Andrew Berchuck; Georgia Chenevix-Trench; Joellen M Schildkraut; Jennifer Permuth-Wey; Catherine M Phelan; Paul D P Pharoah; Brooke L Fridley; Thomas A Sellers; Ellen L Goode Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-01-08 Impact factor: 4.254
Authors: John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; G Larry Maxwell Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Charlotte E Joslin; Katherine C Brewer; Faith G Davis; Kent Hoskins; Caryn E Peterson; Heather A Pauls Journal: Gynecol Oncol Date: 2014-08-28 Impact factor: 5.482
Authors: Maria Theresa M Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Gemma Leonora Uy; Jean Ann Toral; Doris Benavides; Hermann Brenner Journal: BMC Cancer Date: 2009-09-24 Impact factor: 4.430